Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Discover which credit card offers the best cash back for diverse spending. Make informed choices to maximize your rewards!
27,144 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
A new stake in WEX highlights growing confidence in fintech payments as the company reports record revenue. This anal...
In a choppy market shaped by inflation and global tensions, three stocks stand out for potential to beat market retur...
Two years after NVIDIA's stock split, investors again wonder if the AI titan can reach $1,000. This article breaks do...
CrowdStrike delivered a strong quarter, beating earnings and lifting full-year guidance, and even announced a 4-for-1...
A long-term investment thesis centers on a franchise-driven, dividend-growing fast-food operator. The 25-year hold th...
June could huge Apple stock day hinges on upcoming catalysts. This guide breaks down what could drive a big move and ...
Shares of GameStop rallied as investors weighed improved profits, strategic shifts, and mounting retailer momentum. T...
Poet Technologies rose today amid broader AI stock swings. This guide explains what moved the stock, what to watch go...
Middleby Corp. launches its most sweeping restructuring in years, slimming the portfolio to focus on core, higher-mar...
Sabre, a travel-technology stalwart, is navigating a recovering travel market and shifting tech spend. This article b...
Visa and Mastercard posted stronger-than-expected Q1 results as cross-border spending rebounds. The key question for ...